CIK 0001359931 · Non-accelerated filer<br>Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 204580525
- Phone
- 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-19 | Bandari Jathin Chief Medical Officer | Shares withheld for taxes | −2,879 | $1.91 | $5K | 56,704 |
| 2024-01-19 | Bandari Jathin Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +137,000 | 137,000 | ||
| 2024-01-19 | Shefferman Jesse CEO and President | Grant or award | +59,000 | 951,867 | ||
| 2024-01-19 | Shefferman Jesse CEO and President | Shares withheld for taxes | −7,803 | $1.91 | $15K | 944,064 |
| 2024-01-19 | Shefferman Jesse CEO and President | Grant or award · Stock Option (Right to Buy) | +357,000 | 357,000 | ||
| 2024-01-19 | Zummo Jacqueline Chf Scientific Operations Off | Grant or award | +23,000 | 107,345 | ||
| 2024-01-19 | Zummo Jacqueline Chf Scientific Operations Off | Shares withheld for taxes | −3,049 | $1.91 | $6K | 104,296 |
| 2024-01-19 | Zummo Jacqueline Chf Scientific Operations Off | Grant or award · Stock Option (Right to Buy) | +137,000 | 137,000 | ||
| 2024-01-19 | Fabbio Patrick Chief Financial Officer | Grant or award | +22,000 | 22,000 | ||
| 2024-01-19 | Fabbio Patrick Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +131,000 | 131,000 | ||
| 2024-01-19 | Fry Hannah VP, Controller | Grant or award | +8,000 | 30,740 | ||
| 2024-01-19 | Fry Hannah VP, Controller | Shares withheld for taxes | −904 | $1.91 | $2K | 29,836 |
| 2024-01-19 | Fry Hannah VP, Controller | Grant or award · Stock Option (Right to Buy) | +46,000 | 46,000 | ||
| 2024-01-10 | Shefferman Jesse CEO and President | Shares withheld for taxes | −5,746 | $2.39 | $14K | 892,867 |
| 2024-01-10 | Zummo Jacqueline Chf Scientific Operations Off | Shares withheld for taxes | −5,229 | $2.39 | $12K | 84,345 |
| 2024-01-10 | Bandari Jathin Chief Medical Officer | Shares withheld for taxes | −1,877 | $2.39 | $4K | 36,583 |
| 2024-01-03 | Zummo Jacqueline Chf Scientific Operations Off | Shares withheld for taxes | −1,899 | $2.17 | $4K | 89,574 |
| 2024-01-03 | Shefferman Jesse CEO and President | Shares withheld for taxes | −5,840 | $2.17 | $13K | 898,613 |
| 2024-01-03 | Fry Hannah VP, Controller | Shares withheld for taxes | −324 | $2.17 | $703 | 22,740 |
| 2023-07-17 | Fry Hannah VP, Controller | Shares withheld for taxes | −10,075 | $2.56 | $26K | 23,064 |
Page 7 of 8 · 154 trades